Evaluation of Phenobarbital Serum Levels on Clinical Outcomes for the Treatment of Severe Alcohol Withdrawal Syndrome in a Medical Intensive Care Unit
Key Points
This research investigates the relationship between phenobarbital serum levels and clinical outcomes in severe alcohol withdrawal syndrome (AWS).
Evaluated patients admitted to a medical intensive care unit (MICU) for severe AWS.
Analyzed serum levels of phenobarbital in relation to symptom control.
No significant association between phenobarbital serum levels and symptom control was identified.
Findings suggest that serum levels may not correlate with clinical outcomes in severe alcohol withdrawal.
Abstract
No significant evidence was found to suggest that phenobarbital serum levels were associated with symptom control in patients admitted to a MICU for severe AWS as defined in this study.
Perguntar à IA
Like
Bookmark
Share
Perguntar à IA
Like
Bookmark
Share
Evaluation of Phenobarbital Serum Levels on Clinical Outcomes for the Treatment of Severe Alcohol Withdrawal Syndrome in a Medical Intensive Care Unit | Synapse